Eftilagimod alpha | m-entrepreneurship.com

Product Name :
Eftilagimod alpha

Search keywords :
Eftilagimod alfa

drugId :
null

Target Vo:
Lymphocyte activation gene 3 protein

Target Vo Short Name :
LAG3

Moa_Name:
Lymphocyte activation gene 3 protein inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Immutep

Active Company_Name :
Immutep Australia Pty Ltd

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:
Pancreatic Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
3-Nitrotyrosine Antibody
WDR77 Antibody (YA655)
GPX4 Antibody: GPX4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to GPX4. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts